Ikegami Ako, Wake Hiroaki
Department of Anatomy and Molecular Cell Biology, Nagoya University Graduate School of Medicine.
Brain Nerve. 2021 Aug;73(8):913-919. doi: 10.11477/mf.1416201861.
The central nervous system (CNS) is an immune-privileged area. The blood-brain barrier (BBB) is thought to separate the CNS from any systemic inflammatory states to maintain homeostasis within this specialized, vulnerable organ. However, accumulating studies have challenged this concept by demonstrating systemic inflammatory effects on brain. Moreover, the coronavirus disease pandemic caused by severe acute respiratory syndrome coronavirus 2 in 2019 has rapidly evoked attention toward the BBB as the systemic-CNS immunological interface. In this review, we focus on microglia, the sole immune cells in the CNS, and briefly introduce our new findings regarding microglial BBB regulation in systemic inflammation. With a close eye on associated literature, we carefully rethink the traditional immune system in the CNS and suggest a new possible mechanism of systemic-CNS immune cell interaction, while an understanding of the BBB develops.
中枢神经系统(CNS)是一个免疫特权区域。血脑屏障(BBB)被认为将中枢神经系统与任何全身性炎症状态分隔开来,以维持这个特殊的脆弱器官内的稳态。然而,越来越多的研究对这一概念提出了挑战,这些研究表明全身性炎症对大脑有影响。此外,2019年由严重急性呼吸综合征冠状病毒2引起的冠状病毒病大流行迅速引发了人们对血脑屏障作为全身-中枢神经系统免疫界面的关注。在这篇综述中,我们聚焦于小胶质细胞,即中枢神经系统中唯一的免疫细胞,并简要介绍我们关于全身性炎症中小胶质细胞对血脑屏障调节的新发现。密切关注相关文献,我们仔细重新思考了中枢神经系统中的传统免疫系统,并在对血脑屏障的认识不断发展的同时,提出了一种全身-中枢神经系统免疫细胞相互作用的新的可能机制。